205 related articles for article (PubMed ID: 17198786)
1. A novel biomarker for the detection of esophageal adenocarcinoma.
Hammoud ZT; Badve S; Saxena R; Kesler KA; Rieger K; Malkas LH; Hickey RJ
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):82-7. PubMed ID: 17198786
[TBL] [Abstract][Full Text] [Related]
2. Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.
Huang B; Hu B; Su M; Tian D; Guo Y; Lian S; Liu Z; Wu X; Li Q; Zheng R; Gao Y
Hum Pathol; 2011 Jun; 42(6):808-16. PubMed ID: 21237484
[TBL] [Abstract][Full Text] [Related]
3. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
4. Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.
Jaskiewicz K; Louw J; Anichkov N
Anticancer Res; 1994; 14(5A):1907-12. PubMed ID: 7847825
[TBL] [Abstract][Full Text] [Related]
5. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.
Lu D; Vohra P; Chu PG; Woda B; Rock KL; Jiang Z
Am J Surg Pathol; 2009 Apr; 33(4):521-5. PubMed ID: 19047899
[TBL] [Abstract][Full Text] [Related]
6. Assessment of proliferating cell nuclear antigen expression in dysplastic intestinal type Barrett's esophagus. Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
Lapertosa G; Baracchini P; Fulcheri E
Pathologica; 1994 Apr; 86(2):174-9. PubMed ID: 7936762
[TBL] [Abstract][Full Text] [Related]
7. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
Hermann B; Li Y; Ray MB; Wo JM; Martin RC
Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
[TBL] [Abstract][Full Text] [Related]
8. Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus.
Sirieix PS; O'Donovan M; Brown J; Save V; Coleman N; Fitzgerald RC
Clin Cancer Res; 2003 Jul; 9(7):2560-6. PubMed ID: 12855631
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus.
Piaggi S; Marchi S; Ciancia E; Debortoli N; Lazzarotti A; Saviozzi M; Raggi C; Fierabracci V; Visvikis A; Bisgaard HC; Casini AF; Paolicchi A
Oncol Rep; 2009 Feb; 21(2):283-7. PubMed ID: 19148497
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human carcinoma-associated antigen in esophageal adenocarcinoma and its precursor lesions.
Liang S; Yao J; Bourne PA; diSant'Agnese PA; Huang J; Lei JY
Am J Clin Pathol; 2004 Nov; 122(5):747-51. PubMed ID: 15491971
[TBL] [Abstract][Full Text] [Related]
11. [Proliferating cell nuclear antigen in cervical cancer and precursor lesions].
Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Chávez F
Rev Med Chil; 1995 Sep; 123(9):1077-83. PubMed ID: 8728730
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients.
Yakoub D; Keun HC; Goldin R; Hanna GB
Cancer Res; 2010 Nov; 70(22):9129-36. PubMed ID: 20884633
[TBL] [Abstract][Full Text] [Related]
13. Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia.
Sagatys E; Garrett CR; Boulware D; Kelley S; Malafa M; Cheng JQ; Sebti S; Coppola D
Hum Pathol; 2007 Oct; 38(10):1526-31. PubMed ID: 17640711
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
15. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen.
Koga Y; Kuwano H; Sugimachi K
Cancer; 1996 Jan; 77(2):237-44. PubMed ID: 8625229
[TBL] [Abstract][Full Text] [Related]
16. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
17. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
[TBL] [Abstract][Full Text] [Related]
18. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus.
Li H; Zhang L; Lou H; Ding I; Kim S; Wang L; Huang J; Di Sant'Agnese PA; Lei JY
Am J Clin Pathol; 2005 Aug; 124(2):282-7. PubMed ID: 16040301
[TBL] [Abstract][Full Text] [Related]
20. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
